INTU vs TOVX · P/E 64, rev $18.83B vs rev $300.0K
Intuit Inc (INTU) versus Theriva Biologics Inc. (TOVX) — a side-by-side from cached financials, not a winner call.
Intuit Inc (INTU) is a software - application company listed on US.
Theriva Biologics Inc. (TOVX) is a biotechnology company listed on NYSE MKT.
Latest reported INTU revenue for 2025-07-31 was $18.83B. Net income was $3.87B. INTU currently screens at market cap $217.76B and trailing P/E 63.7.
Latest reported TOVX revenue for 2026-06-30 was $300.0K. Net income was -$5.3M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. TOVX currently screens at market cap $12.4M.
INTU currently screens at market cap $217.76B and trailing P/E 63.7. TOVX currently screens at market cap $12.4M.
Not investment advice. Open the INTU and TOVX stock pages for the full models.
Not investment advice.